4 | SEC Filings Hub

Filing metadata

Accession number: 0001610717-24-000164
Form type: Form 4
Filer: AN2 Therapeutics, Inc.
CIK: CIK 1880438
Filed: Mar 18, 2024
Reporting period: Mar 15, 2024
Description: Insider transaction

Documents

0001610717-24-000164-index.htm

Complete submission

0001610717-24-000164.txt

directory listing

Filed by

AN2 Therapeutics, Inc.